Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

AGLE | Aeglea BioTherapeutics Inc

Index- P/E- EPS (ttm)-73.71 Insider Own9.33% Shs Outstand4.05M Perf Week3.29%
Market Cap49.61M Forward P/E- EPS next Y-6.78 Insider Trans0.00% Shs Float3.67M Perf Month-13.73%
Income-272.56M PEG- EPS next Q-0.84 Inst Own70.28% Short Float / Ratio3.30% / 1.94 Perf Quarter8.77%
Sales1.23M P/S40.34 EPS this Y-166.67% Inst Trans- Short Interest0.12M Perf Half Y68.62%
Book/sh-64.00 P/B- EPS next Y89.73% ROA-155.64% Target Price15.62 Perf Year2.92%
Cash/sh58.11 P/C0.21 EPS next 5Y- ROE-163.26% 52W Range2.66 - 39.00 Perf YTD8.91%
Dividend- P/FCF- EPS past 5Y11.19% ROI- 52W High-68.59% Beta2.55
Dividend %- Quick Ratio1.03 Sales past 5Y-42.57% Gross Margin-59.28% 52W Low360.53% ATR1.48
Employees69 Current Ratio1.03 Sales Q/Q10.08% Oper. Margin-6961.16% RSI (14)46.89 Volatility10.44% 13.48%
OptionableNo Debt/Eq- EPS Q/Q-736.54% Profit Margin-22195.36% Rel Volume0.16 Prev Close11.46
ShortableYes LT Debt/Eq- EarningsAug 11 BMO Payout- Avg Volume62.56K Price12.25
Recom2.00 SMA20-6.91% SMA50-7.07% SMA20027.22% Volume10,132 Change6.89%
Date Action Analyst Rating Change Price Target Change
May-04-20Initiated Piper Sandler Overweight $12
Mar-21-19Initiated JP Morgan Overweight $14
Sep-04-18Downgrade Wells Fargo Outperform → Market Perform
Apr-24-18Initiated Evercore ISI Outperform $37
Mar-14-18Reiterated Needham Buy $8 → $12
Sep-14-23 05:03PM
Sep-07-23 08:40AM
Sep-05-23 07:00AM
Aug-11-23 07:07AM
07:00AM
07:00AM Loading…
Jul-27-23 07:00AM
Jun-23-23 04:30PM
10:31AM
Jun-22-23 10:59AM
08:17AM
May-13-23 08:03AM
May-11-23 08:15AM
07:10AM
07:01AM
Apr-13-23 09:44AM
07:00AM Loading…
Apr-12-23 07:00AM
Mar-17-23 05:30PM
Mar-02-23 10:15AM
07:01AM
Feb-12-23 07:40AM
Jan-06-23 07:01AM
Jan-02-23 07:29AM
Dec-14-22 12:00PM
Dec-02-22 04:05PM
Nov-30-22 10:38AM
07:01AM
Nov-15-22 04:25PM
Nov-03-22 08:35AM
07:01AM
Oct-21-22 12:27PM
12:06PM Loading…
12:06PM
Oct-19-22 04:05PM
Oct-17-22 11:57AM
Oct-04-22 11:05AM
07:01AM
Aug-29-22 04:05PM
Aug-27-22 09:18AM
Aug-25-22 11:52AM
Aug-24-22 12:40PM
08:01AM
Aug-22-22 12:28PM
Aug-20-22 10:49AM
Aug-19-22 06:26AM
Aug-18-22 04:05PM
Aug-04-22 08:35AM
07:01AM
Jul-24-22 10:41AM
Jul-08-22 11:14AM
Jul-07-22 11:22AM
Jul-04-22 11:49AM
Jun-29-22 12:34PM
Jun-28-22 11:52AM
10:23AM
Jun-13-22 12:01PM
Jun-09-22 09:56AM
Jun-03-22 10:49AM
Jun-02-22 03:26PM
03:20PM
12:09PM
11:24AM
08:59AM
Jun-01-22 02:25PM
02:22PM
May-31-22 11:26AM
May-26-22 11:18AM
May-25-22 12:07PM
May-23-22 11:46AM
11:33AM
May-20-22 09:50AM
May-18-22 11:47AM
11:03AM
May-17-22 11:31AM
May-13-22 10:30AM
May-11-22 09:47AM
May-05-22 09:28AM
07:45AM
06:30AM
Apr-13-22 12:42PM
Apr-12-22 08:10AM
06:01AM
Apr-11-22 04:30PM
Apr-06-22 07:59AM
Mar-29-22 07:59AM
Mar-08-22 08:35AM
Feb-10-22 09:29AM
Feb-09-22 04:01PM
Feb-02-22 04:39AM
Jan-25-22 08:01AM
Jan-05-22 07:01AM
Dec-17-21 06:14AM
Dec-14-21 09:15AM
Dec-12-21 06:18AM
Dec-06-21 01:01PM
07:18AM
06:30AM
Dec-05-21 06:00PM
Nov-16-21 07:01AM
Nov-04-21 08:55AM
07:01AM
06:59AM
Aeglea Biotherapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of next-generation human enzyme therapeutics as disruptive solutions for rare and other high-burden diseases. Its product, Pegzilarginase, is in a Phase 3 pivotal trial for the treatment of Arginase 1 Deficiency. The company was founded by George Georgiou and David G. Lowe in December 2013 and is headquartered in Waltham, MA.